Psynomics, Inc. Announces Gene Tests for Psychiatric Bipolar Disorder

SAN DIEGO, CA--(Marketwire - February 04, 2008) - Psynomics, Inc., a privately held life-sciences company offering innovative genetic screening products and services for neuropsychiatric illnesses, today announced that two tests for bipolar disorder are available for purchase on its web-site, along with descriptions, references and instructions. Either patients or their physicians may order the simple, non-invasive kits to collect DNA samples from saliva and the results are reported confidentially to the patient's physician.